Becton, Dickinson and Company
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Becton, Dickinson and Company
The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.
Christopher Barry, a former VP of R&D at Bard subsidiary Lutonix, pleaded guilty to one count of theft of trade secrets. He now faces up to two and a half years in prison.
Ventral hernia repair is associated with a relatively high incidence of microbial contamination of the surgical site, ranging from 8% to 40%. To combat infection, Ariste Medical LLC has developed a mid-weight hernia mesh that features a proprietary polymer coating embedded with a programmed release of two proven antimicrobials.
A sortable and searchable table of FDA original PMAs and panel-track supplements approved in calendar year 2016, updated monthly. Latest update: Approvals through April 30.